Capital Flow Monitor · Sponsors · CIK 1921865
ASP Isotopes Inc.
2200 ROSS AVENUE, SUITE 4575E, DALLAS, TX, 75201 · 202-756-2245
Other · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$109.2M
Sold
$109.2M
% sold
100.0%
Investors
11
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-17 | D ·current | 506(b) | $109.2M | $109.2M | 100.0% | 11 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Paul E. Mann — Executive Officer / Director, Dallas, TX
1 other raise
- Noble Africa LLC $20.8M of $20.8M · 100.0%
- Michael Gorley — Director, Dallas, TX
- Ralph L. Hunter, Jr. — Director, Dallas, TX
- Sipho N. Maseko — Director, Dallas, TX
- Duncan Moore — Director, Dallas, TX
-
Robert Ryan — Director, Dallas, TX
1 other raise
- Caeruleus Fund $2.39B of —
-
Todd Wider — Director, Dallas, TX
2 other raises
- IsoBio, Inc. $1.7M of $3.0M · 57.4%
- Xanadu Bio, Inc. $11.0M of $11.0M · 100.0%
-
Heather Kiessling — Executive Officer, Dallas, TX
1 other raise
- Noble Africa LLC $20.8M of $20.8M · 100.0%
- Robert Ainscow — Executive Officer, Dallas, TX
- Donald Ainscow — Executive Officer, Dallas, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.